OBJECTIVE: To explore the risk factors and prognosis of @entity551 in postoperative sedation @entity1 . METHODS: A total of 175 @entity1 with postoperative sedation at our department from May 2013 to March 2014 were retrospectively reviewed. @entity1 with age <18 years, cardiac surgery, @entity1911 surgery, @entity548 , @entity326 or @entity1455 were excluded. APACHE II, dosage and duration of sedative drug, mean arterial pressure at baseline and after sedation, central venous pressure, fluid balance, dosage and duration of @entity1063 , endotracheal intubation time and length of intensive care unit (ICU) stay were recorded. RESULTS: Blood pressures decreased significantly after administration of sedation (77.2    11.2 vs 82.6    9.3 mmHg, P = 0.000). Compared to those with lower disease severity (APACHEII  <= 10), the @entity1 with APACHEII.>10 required higher @entity1063 dosage and longer time of infusion. A longer time of @entity1063 infusion was needed for @entity1 with @entity301 . @entity1 undergoing @entity1514 , abdominal or pelvic surgery, or those with @entity409 had a higher @entity1063 dosage. @entity551 and @entity1063 duration were independent risk factors of endotracheal intubation time. And dosage and duration of @entity1063 were independent risk factors of ICU time. CONCLUSION: Disease severity, past history of @entity299 , surgical site and liver function are risk factors of @entity551 in postoperative sedation @entity1 . It is important to pay attention to dosage and administrative route of sedative drug. @entity1063 duration after sedation is an independent risk factor of endotracheal intubation time and ICU time.

[Risk factors and prognosis of @entity551 in postoperative sedation XXXX ].

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity1455 :: ('MESH:D012770', 'Disease') :: ['cardiogenic shock'] @entity548 :: ('MESH:D006470', 'Disease') :: ['hemorrhagic shock'] @entity326 :: ('MESH:D012772', 'Disease') :: ['septic shock'] @entity1911 :: ('MESH:D010673', 'Disease') :: ['pheochromocytoma'] @entity301 :: ('MESH:D003327', 'Disease') :: ['coronary heart disease'] @entity409 :: ('MESH:D008107', 'Disease') :: ['hepatic dysfunction'] @entity1514 :: ('MESH:D013896', 'Disease') :: ['thoracic'] @entity299 :: ('MESH:D006331', 'Disease') :: ['heart disease'] @entity1063 :: ('MESH:D009638', 'Chemical') :: ['Norepinephrine', 'norepinephrine'] @entity551 :: ('MESH:D007022', 'Disease') :: ['hypotension', 'Decrement of blood pressure']
@entity1 :: (9606,Species) :: ['patients']
